Sarah Tomaszewski Farias1, Karen Lau2, Danielle Harvey3, Katherine G Denny1, Cheyanne Barba1, Anthony N Mefford1. 1. Department of Neurology, School of Medicine, University of California, Davis, Sacramento, California. 2. Department of Psychiatry, Marin/Sonoma Service Area, Kaiser Permanente Northern California, The Permanente Medical Group, San Rafael, California. 3. Division of Biostatistics, Department of Public Health Sciences, School of Medicine, University of California, Davis, Davis, California.
Abstract
OBJECTIVES: To examine whether specific types of early functional limitations in cognitively normal older adults are associated with subsequent development of mild cognitive impairment (MCI), as well as the relative predictive value of self versus informant report in predicting diagnostic conversion to MCI. DESIGN: As a part of a longitudinal study design, participants underwent baseline and annual multidisciplinary clinical evaluations, including a physical and neurological examination, imaging, laboratory work, and neuropsychological testing. SETTING: Data used in this study were collected as part of longitudinal research at the University of California, Davis Alzheimer's Disease Center. PARTICIPANTS: Individuals diagnosed as having normal cognition at study baseline who had an informant who could complete informant-based ratings and at least one follow-up visit (N = 324). MEASUREMENTS: Participants and informants each completed the Everyday Cognition Scale (ECog), an instrument designed to measure everyday function in six cognitively relevant domains. RESULTS: Self- and informant-reported functional limitations on the ECog were associated with significantly greater risk of diagnostic conversion to MCI (informant: hazard ratio (HR) = 2.0, 95% confidence interval (CI) = 1.3-3.2, P = .002), with self-report having a slightly higher hazard (HR = 2.3, 95% CI = 1.4-3.6, P < .001). When controlling for baseline cognitive abilities, the effect remained significant for self- and informant-reported functional limitations. CONCLUSION: Deficits in everyday memory and executive function domains were the strongest predictors of diagnostic conversion to MCI. Detection of early functional limitations may be clinically useful in assessing the future risk of developing cognitive impairment in cognitively normal older adults.
OBJECTIVES: To examine whether specific types of early functional limitations in cognitively normal older adults are associated with subsequent development of mild cognitive impairment (MCI), as well as the relative predictive value of self versus informant report in predicting diagnostic conversion to MCI. DESIGN: As a part of a longitudinal study design, participants underwent baseline and annual multidisciplinary clinical evaluations, including a physical and neurological examination, imaging, laboratory work, and neuropsychological testing. SETTING: Data used in this study were collected as part of longitudinal research at the University of California, Davis Alzheimer's Disease Center. PARTICIPANTS: Individuals diagnosed as having normal cognition at study baseline who had an informant who could complete informant-based ratings and at least one follow-up visit (N = 324). MEASUREMENTS: Participants and informants each completed the Everyday Cognition Scale (ECog), an instrument designed to measure everyday function in six cognitively relevant domains. RESULTS: Self- and informant-reported functional limitations on the ECog were associated with significantly greater risk of diagnostic conversion to MCI (informant: hazard ratio (HR) = 2.0, 95% confidence interval (CI) = 1.3-3.2, P = .002), with self-report having a slightly higher hazard (HR = 2.3, 95% CI = 1.4-3.6, P < .001). When controlling for baseline cognitive abilities, the effect remained significant for self- and informant-reported functional limitations. CONCLUSION: Deficits in everyday memory and executive function domains were the strongest predictors of diagnostic conversion to MCI. Detection of early functional limitations may be clinically useful in assessing the future risk of developing cognitive impairment in cognitively normal older adults.
Authors: Denise C Park; Angela H Gutchess; Michelle L Meade; Elizabeth A L Stine-Morrow Journal: J Gerontol B Psychol Sci Soc Sci Date: 2007-06 Impact factor: 4.077
Authors: M H Tabert; S M Albert; L Borukhova-Milov; Y Camacho; G Pelton; X Liu; Y Stern; D P Devanand Journal: Neurology Date: 2002-03-12 Impact factor: 9.910
Authors: A J Saykin; H A Wishart; L A Rabin; R B Santulli; L A Flashman; J D West; T L McHugh; A C Mamourian Journal: Neurology Date: 2006-09-12 Impact factor: 9.910
Authors: Alicia D Rueda; Karen M Lau; Naomi Saito; Danielle Harvey; Shannon L Risacher; Paul S Aisen; Ronald C Petersen; Andrew J Saykin; Sarah Tomaszewski Farias Journal: Alzheimers Dement Date: 2014-11-15 Impact factor: 21.566
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: Tanya R Gure; Kenneth M Langa; Gwenith G Fisher; John D Piette; Brenda L Plassman Journal: J Geriatr Psychiatry Neurol Date: 2013-04-04 Impact factor: 2.680
Authors: Katherine J Bangen; Alexandra J Weigand; Kelsey R Thomas; Lisa Delano-Wood; Lindsay R Clark; Joel Eppig; Madeleine L Werhane; Emily C Edmonds; Mark W Bondi Journal: Neuropsychology Date: 2019-03-21 Impact factor: 3.295
Authors: Katherine L Possin; Tacie Moskowitz; Sabrina J Erlhoff; Kirsten M Rogers; Erica T Johnson; Natasha Z R Steele; Joseph J Higgins; Jordan Stiver; Andrea G Alioto; Sarah T Farias; Bruce L Miller; Katherine P Rankin Journal: J Am Geriatr Soc Date: 2018-01 Impact factor: 5.562
Authors: Katherine J Bangen; Kelsey R Thomas; Alexandra J Weigand; Danielle L Sanchez; Lisa Delano-Wood; Emily C Edmonds; Owen T Carmichael; Christopher G Schwarz; Adam M Brickman; Mark W Bondi Journal: Neurobiol Aging Date: 2019-11-02 Impact factor: 4.673
Authors: Douglas Barthold; Zachary A Marcum; Shuxian Chen; Lindsay White; Nagham Ailabouni; Anirban Basu; Norma B Coe; Shelly L Gray Journal: J Gen Intern Med Date: 2020-10-09 Impact factor: 5.128
Authors: Ronald C Petersen; Heather J Wiste; Stephen D Weigand; Julie A Fields; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Walter K Kremers; Val Lowe; Mary M Machulda; Michelle M Mielke; Nikki H Stricker; Terry M Therneau; Prashanthi Vemuri; Clifford R Jack Journal: Ann Neurol Date: 2021-04-06 Impact factor: 11.274
Authors: Brenna Cholerton; Kathleen L Poston; Lu Tian; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Shu-Ching Hu; Krista Specketer; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian Journal: Mov Disord Clin Pract Date: 2019-12-14
Authors: Argonde C van Harten; Michelle M Mielke; Dana M Swenson-Dravis; Clinton E Hagen; Kelly K Edwards; Rosebud O Roberts; Yonas E Geda; David S Knopman; Ronald C Petersen Journal: Neurology Date: 2018-06-29 Impact factor: 11.800